Novartis Claims 100% Tariff on Branded Pharmaceuticals Will Not Affect Them
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 26 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Tariff Announcement: Novartis announced a 100% tariff on branded or patented pharmaceuticals, impacting pricing and accessibility.
Market Implications: The new tariff could lead to significant changes in the pharmaceutical market, affecting both companies and consumers.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
